Belluscura plc

Equities

BELL

GB00BD3B8Z11

Medical Equipment, Supplies & Distribution

Delayed London S.E. Other stock markets 02:59:59 2024-05-08 am EDT			5-day change	1st Jan Change
8 ^GBX	0.00%		+10.34%	-65.22%

Apr. 02	Belluscura sees financial hit from delay to closing TMT acquisition	AN
Apr. 02	AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist	AN

Belluscura plc Reports Earnings Results for the Half Year Ended June 30, 2021

September 06, 2021 at 02:00 am EDT

Belluscura plc announced earnings results for the half year ended June 30, 2021. For the half year, the company announced operating loss was USD 2.431 million compared to operating Income of USD 23,099 a year ago. Net loss was USD 2.445 million compared to net income of USD 6,279 a year ago. Basic loss per share from continuing operations was USD 0.039 compared to USD 0.009 a year ago.

Latest news about Belluscura plc

Belluscura sees financial hit from delay to closing TMT acquisition	Apr. 02	AN
AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist	Apr. 02	AN
Belluscura plc Provides Earnings Guidance for the Full Year 2024	Apr. 02	CI
Belluscura Amasses 98% Stake in TMT Acquisition	Mar. 11	MT
Belluscura plc completed the acquisition of TMT Acquisition Plc.	Mar. 07	CI
TMT Acquisition Delists from London Bourse	Mar. 07	MT
Belluscura to Launch Mandatory Acquisition of Remaining TMT Shares	Feb. 19	MT
FTSE 100 Closes Lower as Equities Slid on U.S. Inflation Data	Feb. 13	DJ
Belluscura Enters Oxygen Concentrator Distribution Deal With US-based Sunset Healthcare	Feb. 13	MT
Belluscura plc Announces Implementation of Distribution Agreement with Sunset Healthcare Solutions	Feb. 13	CI
FTSE 100 Closes Down 0.3% Dragged by Miners, Financial Stocks	Feb. 09	DJ
Belluscura Declares TMT Acquisition Offer Unconditional	Feb. 09	MT
AIM WINNERS & LOSERS: Belluscura shares up as wraps up TMT takeover	Feb. 09	AN
Belluscura rises as TMT Acquisition takeover offer becomes unconditional	Feb. 09	AN
Nexxen expands partnership; Geiger considers listing	Feb. 08	AN
Belluscura Awaits AIM Admission of Shares to Declare TMT Acquisition Unconditional	Feb. 08	MT
Belluscura says all but one condition satisfied for TMT buy	Feb. 07	AN
Belluscura plc completed the acquisition of 89% stake in TMT Acquisition Plc for £4.7 million.	Feb. 01	CI
MicroSalt shares jump after IPO but investor Tekcapital falls	Feb. 01	AN
Tekcapital shares fall but "excited" as MicroSalt completes IPO	Feb. 01	AN
Tekcapital raises GBP570,000 via sale of Belluscura shares	Jan. 24	AN
UK Investment Group Tekcapital Cuts Stake in Medical Device Company Belluscura	Jan. 24	MT
TMT accepts revised offer terms from Belluscura	Jan. 19	AN
K3 Business says cash balances ahead of forecast	Dec. 20	AN
Belluscura Granted Chinese Distribution Approval for Oxygen Concentrator	Dec. 20	MT

Chart Belluscura plc

Duration

Period

More charts

Company Profile

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-09-01 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Belluscura plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.1003 USD

Average target price

0.4652 USD

Spread / Average Target

+363.62%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BELLUSCURA PLC	-65.22%	16.56M
ABBOTT LABORATORIES	-3.54%	185B
MEDTRONIC PLC	-0.58%	109B
BECTON, DICKINSON AND COMPANY	-2.74%	68.54B
DEXCOM, INC.	+4.84%	51.74B
CENCORA, INC.	+10.40%	45.22B
HOYA CORPORATION	+3.12%	41.74B
WEST PHARMACEUTICAL SERVICES, INC.	+4.61%	26.83B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.87%	26.69B
TERUMO CORPORATION	+11.62%	25.63B

Other Medical Equipment, Supplies & Distribution